University of Connecticut: Sickle Cell Drug Showing Promise in Clinical Trial
June 20, 2019
June 20, 2019
STORRS, Connecticut, June 20 [TNSmedicalresearch] -- The University of Connecticut issued the following news:
An investigational drug for the treatment of sickle cell disease is showing early promise in clinical trials for impacting biomarkers of the disease in patients, reported UConn School of Medicine researchers at the European Hematology Association Congress in Amsterdam this week.
For the rare, painful red blood cell disease, which impacts blood circulation, pre-c . . .
An investigational drug for the treatment of sickle cell disease is showing early promise in clinical trials for impacting biomarkers of the disease in patients, reported UConn School of Medicine researchers at the European Hematology Association Congress in Amsterdam this week.
For the rare, painful red blood cell disease, which impacts blood circulation, pre-c . . .